The place of memantine in the treatment of Alzheimer's disease: a number needed to treat analysis.
Livingston
Gill
G
Department of Mental Health Sciences/Camden and Islington Mental Health and Social Care Trust, University College London, N19 5LW London, UK. g.livingston@ucl.ac.uk
Katona
Cornelius
C
D000203:Activities of Daily Living; D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D003071:Cognition / Q000187:drug effects; D015259:Dopamine Agents / Q000627:therapeutic use*; D006801:Humans; D008559:Memantine / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D018401:Sample Size; D016896:Treatment Outcome
D015259:Dopamine Agents; D008559:Memantine